Pass It On…Until Every Woman Knows about Personalized Breast Cancer Treatment

Not every woman with early-stage breast cancer needs aggressive treatment. There is a genomic test that can help determine if she will. But up to half of the women* with early-stage breast cancer who are eligible for the test aren't getting the test.

Women get one chance to make the best treatment decision for their breast cancer – when they are diagnosed. Whether it’s chemotherapy for early-stage invasive breast cancer or post-surgery treatment for DCIS, they need to ask their doctor for the Oncotype DX breast cancer test and get their Oncotype DX score result.


Get your Oncotype DX score result before you make your treatment decision.


Join the others who want to share the message Until Every Woman Knows About Personalized Breast Cancer Treatment. #UntilEveryWomanKnows

*U.S. patients